Bausch Health Cos Total Liabilities and Share Holders Equity 2010-2024 | BHC

Bausch Health Cos total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Bausch Health Cos Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $27,350
2022 $25,686
2021 $29,202
2020 $31,199
2019 $33,863
2018 $32,492
2017 $37,497
2016 $43,529
2015 $48,965
2014 $26,305
2013 $27,971
2012 $17,950
2011 $13,108
2010 $10,795
2009 $2,059
Bausch Health Cos Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-06-30 $26,495
2024-03-31 $26,913
2023-12-31 $27,350
2023-09-30 $27,064
2023-06-30 $25,503
2023-03-31 $25,445
2022-12-31 $25,686
2022-09-30 $26,298
2022-06-30 $28,171
2022-03-31 $29,090
2021-12-31 $29,202
2021-09-30 $29,252
2021-06-30 $30,042
2021-03-31 $30,197
2020-12-31 $31,199
2020-09-30 $31,562
2020-06-30 $31,396
2020-03-31 $31,865
2019-12-31 $33,863
2019-09-30 $31,667
2019-06-30 $32,354
2019-03-31 $32,551
2018-12-31 $32,492
2018-09-30 $33,777
2018-06-30 $34,448
2018-03-31 $35,798
2017-12-31 $37,497
2017-09-30 $39,974
2017-06-30 $41,733
2017-03-31 $42,333
2016-12-31 $43,529
2016-09-30 $45,761
2016-06-30 $47,662
2016-03-31 $49,020
2015-12-31 $48,965
2015-09-30 $48,455
2015-06-30 $48,343
2015-03-31 $38,566
2014-12-31 $26,305
2014-09-30 $27,060
2014-06-30 $27,896
2014-03-31 $27,989
2013-12-31 $27,971
2013-09-30 $28,204
2013-06-30 $19,782
2013-03-31 $17,486
2012-12-31 $17,950
2012-09-30 $14,146
2012-06-30 $14,020
2012-03-31 $13,620
2011-12-31 $13,108
2011-09-30 $11,818
2011-06-30 $11,828
2011-03-31 $11,688
2010-12-31 $10,795
2010-09-30 $11,136
2010-06-30 $2,030
2010-03-31 $2,005
2009-12-31 $2,059
2009-09-30 $2,022
2009-06-30 $2,058
2009-03-31 $1,557
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.956B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.120B 6.83
Dr Reddy's Laboratories (RDY) India $13.079B 19.59
BridgeBio Pharma (BBIO) United States $5.045B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.438B 13.65
Supernus Pharmaceuticals (SUPN) United States $1.771B 357.00
Taysha Gene Therapies (TSHA) United States $0.449B 73.00
Personalis (PSNL) United States $0.315B 0.00
Assembly Biosciences (ASMB) United States $0.117B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00